Dr. McGarry is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1210 Brace Rd
Ste 100
Cherry Hill, NJ 08034Phone+1 856-342-2445Fax+1 856-270-4085
Education & Training
- University of RochesterResidency, Neurology, 2005 - 2008
- University of RochesterInternship, Internal Medicine, 2004 - 2005
- Rutgers Robert Wood Johnson Medical SchoolClass of 2004
Certifications & Licensure
- NJ State Medical License 2011 - 2025
- NY State Medical License 2008 - 2011
- American Board of Psychiatry and Neurology Neurology
Clinical Trials
- Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E) Start of enrollment: 2009 Sep 01
Publications & Presentations
PubMed
- 152 citationsEffect of Deutetrabenazine on Chorea Among Patients With Huntington Disease: A Randomized Clinical TrialSamuel Frank, Claudia M. Testa, David Stamler, Elise Kayson, Charles S. Davis
JAMA. 2016-07-05 - 85 citationsA randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington diseaseAndrew McGarry, Michael P. McDermott, Karl Kieburtz, Elisabeth A. deBlieck, Flint Beal
Neurology. 2017-01-10 - 15 citationsEffects of Pridopidine on Functional Capacity in Early-Stage Participants from the PRIDE-HD Study.Andrew McGarry, Mika Leinonen, Karl Kieburtz, Michal Geva, C. Warren Olanow
Journal of Huntington's Disease. 2020-01-01
Press Mentions
- AAN Members Only: Sign in with Your AAN Member Credentials (Email or 6-Digit Member ID Number)January 10th, 2017
- Can a GLP-1 Agonist Improve Parkinson's Symptoms?December 24th, 2023
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: